Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro

References

1. Anand A., Gray E. S., Brown T., Clewley J. P., Cohen B. J. 1987; Human parvovirus infections in pregnancy and hydrops fetalis. New England Journal of Medicine 316:183–186
   [Google Scholar]
2. Anderson M. J. 1987; Human parvovirus infections. Journal of Virological Methods 17:175–181
   [Google Scholar]
3. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L. R., Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Human parvovirus, the cause of erythema infectiosum (fifth disease). Lancet i:1378
   [Google Scholar]
4. Anderson M. J., Kidd I. M., Morgan-Capner P. 1985; Human parvovirus and rubella-like illness. Lancet ii:663
   [Google Scholar]
5. Brown K. E. 1989; What threat is human parvovirus B19 to the foetus?. British Journal of Obstetrics and Gynaecology 96:764–767
   [Google Scholar]
6. Brown K. E., Mori J., Cohen B. J., Field A. M. 1991; In vitro propagation of parvovirus B19 in primary foetal liver culture. Journal of General Virology 72:741–745
   [Google Scholar]
7. Clewley J. P., Cohen B. J., Field A. M. 1987; Detection of parvovirus B19 DNA, antigen and particles in the human fetus. Journal of Medical Virology 23:367–376
   [Google Scholar]
8. Cohen B. J., Buckley M. M., Clewley J. P., Jones V. E., Puttick A. H., Jacoby R. K. 1986; Human parvovirus infection in early rheumatoid and inflammatory arthritis. Annals of the Rheumatic Diseases 45:832–838
   [Google Scholar]
9. Cunningham A. L., Fraser J. R. 1985a; Ross River virus infection of human synovial cells in vitro. Australian Journal of Experimental Biology and Medical Sciences 63:199–204
   [Google Scholar]
10. Cunningham A. L., Fraser J. R. 1985b; Persistent rubella virus infection of human synovial cells cultured in vitro. Journal of Infectious Diseases 151:638–645
    [Google Scholar]
11. Dijkmans B. A. C., van Elsacker-Niele A. M. W., Salimans M. M. M., van Albada-Kuipers G. A., de Vries E., Weiland H. T. 1988; Hurpan parvovirus B19 DNA in synovial fluid. Arthritis and Rheumatism 31:279–281
    [Google Scholar]
12. Editorial 1985; Arthritis and parvovirus infection. Lancet i:436–438
    [Google Scholar]
13. Ford D. J., Tingle A. J., Chantler J. K. 1988; Rubella arthritis. In Infections in the Rheumatic Diseases vol 14 pp 103–106 Edited by Espinoza L., Goldenberg D. L., Arnett F. C., Alarcon G. S. New York: Grune & Stratton;
    [Google Scholar]
14. Huppertz H. I., Miki N. P. H., Chantler J. K. 1991; Susceptibility of normal human joint tissue to viruses. Journal of Rheumatology 18:699–704
    [Google Scholar]
15. Miki N. P. H., Chantler J. K. 1992; Differential ability of wild-type and vaccine strains of rubella virus to replicate and persist in human joint tissue. Clinical Experimental Rheumatology 10:1–10
    [Google Scholar]
16. Mortimer P. P., Humphries R. K., Moore J. F., Purcell R. H., Young N. S. 1983; A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature, London 302:426–429
    [Google Scholar]
17. Ozawa K., Kurtzman G., Young N. 1987; Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70:384–391
    [Google Scholar]
18. Reid D. M., Reid T. M. S., Brown T., Rennie J. A. N., Eastmond J. 1985; Human parvovirus associated arthritis: a clinical and laboratory description. Lancet i:422–425
    [Google Scholar]
19. Rosenthal L. J., Crutchfield D. B., Panitz P. J., Clanton D. J. 1983; Isolation of human cytomegalovirus DNA from infected cells. Intervirology 19:113–120
    [Google Scholar]
20. Saarinen V. M., Chorba T. L., Tattersall P., Young N. S., Anderson L. J., Palmer E., Coccia P. F. 1986; Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 67:1411–1417
    [Google Scholar]
21. Salimans M. M. M., van de Ruke F. M., Raap A. K., van Elsacker-Niele A. M. W. 1989; Detection of parvovirus B19 DNA in fetal tissues by in situ hybridization and polymerase chain reaction. Journal of Clinical Pathology 42:525–530
    [Google Scholar]
22. Simpson R. W., Mcginty L., Simon L., Smith C. A., Godzeski C. W., Boyd R. J. 1984; Association of parvoviruses with rheumatoid arthritis of humans. Science 223:1425–1428
    [Google Scholar]
23. Srivastava A., Lu L. 1988; Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells for normal human bone marrow. Journal of Virology 62:3059–3063
    [Google Scholar]
24. Stierle G., Brown K. A., Rainsford S. G., Smith C. A., Hamerman D., Stierle H. E., Dumonde D. C. 1987; Parvovirus associated antigen in the synovial membrane of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 46:219–223
    [Google Scholar]
25. Summers J., Jones S. E., Anderson M. J. 1983; Biochemical characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. Journal of General Virology 64:2527–2532
    [Google Scholar]
26. White D. G., Mortimer P. P., Blake D. R., Woolf A. D., Cohen B. J., Bacon P. A. 1985; Human parvovirus arthropathy. Lancet i:419–421
    [Google Scholar]
27. Yaegashi N., Shiraishi H., Takeshita T., Nakamura M., Yajima A., Sugamara K. 1989; Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. Journal of Virology 632422–2426
    [Google Scholar]